Advertisement

Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study

Published:February 15, 2008DOI:https://doi.org/10.1016/j.jhep.2008.01.024

      Background/Aims

      Low protein concentration in ascitic fluid has been identified as a risk factor for spontaneous bacterial peritonitis (SBP). Until now, primary prophylaxis has not been recommended in these patients. The aim was to investigate the efficacy of long-term administration of ciprofloxacin to prevent SBP.

      Methods

      One hundred cirrhotic patients with <1.5 g/dl of total protein in ascitic fluid were randomized prospectively, in a double blind fashion to receive ciprofloxacin 500 mg/day (n = 50) or placebo (n = 50) for 12 months.

      Results

      Baseline data were similar in both groups. In the ciprofloxacin group, SBP occurred almost four times less frequently than in the placebo group but it was not statistically significant. The probability of survival at 12 months was significantly higher in patients receiving ciprofloxacin (86% versus 66%) (p < 0.04). SBP and sepsis were the most frequent causes of death in the placebo group whereas gastrointestinal bleeding was responsible for the most deaths in the ciprofloxacin group. The probability of remaining free of bacterial infections was higher in patients receiving ciprofloxacin (80% versus 55%) (p = 0.05).

      Conclusions

      Patients with cirrhosis and low protein concentration in ascitic fluid are candidates to receive long-term prophylaxis to reduce the risk of infections and improve survival.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • García Tsao G.
        Spontaneous bacterial peritonitis.
        Gastroenterol Clin North Am. 1992; 21: 257-275
        • Caly W.
        • Strauss E.
        A prospective study of bacterial infections in patients with cirrhosis.
        J Hepatol. 1993; 18: 353-358
        • Pinzello G.
        • Simonetti R.
        • Craxi A.
        • Di Piazza S.
        • Spano C.
        • Pagliaro L.
        Spontaneous bacterial perotinitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients.
        Hepatology. 1983; 3: 545-549
        • Levi D.
        • Terg R.
        • Podesta A.
        • Abecasis R.
        • Deglee G.
        • Raffaelli C.
        Infecciones bacterianas en el paciente cirrótico.
        Gastroenterologia y Hepatología. 1989; 12: 384-388
        • Sort P.
        • Navasa M.
        • Arroyo V.
        • Aldeguer X.
        • Planas R.
        • Ruiz del Arbol L.
        • et al.
        Effects of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
        N Engl J Med. 1999; 341: 403-409
        • Ginés P.
        • Rimola A.
        • Planas R.
        • Vargas V.
        • Marco F.
        • Almela M.
        • et al.
        Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial.
        Hepatology. 1990; 12: 716-724
        • Tito L.I.
        • Rímola A.
        • Ginés P.
        • Llach J.
        • Arroyo V.
        • Rodés J.
        Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors.
        Hepatology. 1988; 8: 27-31
        • Silvain C.
        • Besson I.
        • Ingrand P.
        • Mannant P.R.
        • Fort E.
        • Beuchant M.
        Prognosis and long-term recurrence of spontaneous bacterial peritonitis in cirrhosis.
        J Hepatol. 1993; 19: 188-189
        • Terg R.
        • Levi D.
        • Lopez P.
        • Rafaelli C.
        • Rojter S.
        • Abecasis R.
        • et al.
        Analysis of clinical course and prognosis of culture positive spontaneous bacterial peritonitis and neutrocytic ascites. Evidence of the same disease.
        Dig Dis Sci. 1992; 37: 1499-1504
        • Bernard B.
        • Grangé G.J.
        • Khac E.
        • Amio X.
        • Opolon P.
        • Poynard T.
        Antibiotics prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
        Hepatology. 1999; 29: 1655-1661
        • Hou M.
        • Lin H.
        • Liu T.
        • Kuo B.
        • Lee F.
        • Chang F.
        • et al.
        Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial.
        Hepatology. 2004; 39: 746-753
        • Llach J.
        • Rimola A.
        • Navasa M.
        • Gines P.
        • Salmeron J.M.
        • Gines A.
        • et al.
        Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration.
        Hepatology. 1992; 16: 724-727
        • Runyon B.
        Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis.
        Gastroenterology. 1986; 91: 1343-1346
        • Novella M.
        • Solá R.
        • Soriano G.
        • Andreu M.
        • Gana J.
        • Ortiz J.
        • et al.
        Continuous vs. inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis in cirrhotic patients with norfloxacin.
        Hepatology. 1997; 25: 532-536
        • Grange J.D.
        • Roulot D.
        • Pelletier G.
        • Pariente E.A.
        • Denis J.
        • Ink O.
        • et al.
        Primary prophylaxis of bacterial infections with norfloxacin in cirrhotic patients with ascites: results of a double-blind, placebo-controlled trial.
        J Hepatol. 1998; 29: 430-436
        • Rolachon A.
        • Cordier L.
        • Bacq Y.
        • Nousbaum J.B.
        • Franza A.
        • Paris J.C.
        • et al.
        Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.
        Hepatology. 1995; 22: 1171-1174
        • Singh N.
        • Gayowski T.
        • Yu V.L.
        • Wagener M.M.
        Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomised trial.
        Ann Intern Med. 1995; 122: 595-598
        • Guarner C.
        • Solá R.
        • Soriano G.
        • Andreu M.
        • Novella M.
        • Vila M.
        • et al.
        Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotic with low ascitic fluid protein levels.
        Gastroenterology. 1999; 117: 414-419
        • Fernandez J.
        • Navasa M.
        • Planas R.
        • Montoliu S.
        • Montfort D.
        • Soriano G.
        • et al.
        Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improve survival in cirrhosis.
        Gastroenterology. 2007; 133: 818-824
        • Singh N.
        • Wagener M.
        • Gayowski T.
        Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit.
        Clin Microbiol Infect. 2003; 9: 531-537
        • Fernandez J.
        • Navasa M.
        • Gomez J.
        • Colmenero J.
        • Vila J.
        • Arroyo V.
        • et al.
        Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
        Hepatology. 2002; 35: 140-148
        • Dupeyron C.
        • Mangeney N.
        • Sedrati L.
        • Campillo B.
        • Fouet P.
        • Leluan G.
        Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.
        Antimicrob Agents Chemother. 1994; 38: 340-344
        • Campillo B.
        • Dupeyron C.
        • Richardet J.
        • Mangeney N.
        • Leluan G.
        Epidemiology of severe hospital acquired infections in patients with liver cirrhosis: effects of long term administration of norfloxacin.
        Clin Infect Dis. 1998; 26: 1066-1070
        • Cirera I.
        • Bauer T.
        • Navasa M.
        • Vila J.
        • Grande L.
        • Taura P.
        • et al.
        Bacterial translocation of enteric organism in patients with cirrhosis.
        J Hepatol. 2001; 34: 32-37
        • Runyon B.
        • Borzio M.
        • Young S.
        • Squier S.
        • Guarner C.
        • Runyon M.
        Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation and survival in an animal model of cirrhosis.
        Hepatology. 1995; 21: 1719-1724
        • Llovet J.
        • Bartolí R.
        • Planas R.
        • Viñado B.
        • Arnal J.
        • Ojanguren I.
        • et al.
        Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to haemorrhagic shock.
        Hepatology. 1996; 23: 781-787
        • Chin-Dusting J.
        • Rasaratnam B.
        • Jennings G.
        • Dudley F.
        Effect of fluoroquinolone on the enhanced nitric oxide induced peripheral vasodilation seen in cirrhosis.
        Ann Int Med. 1997; 127: 985-988
        • Rasaratnam B.
        • Kaye D.
        • Jenning G.
        • Dudley F.
        • Chin-Dustin J.
        The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis.
        Ann Intern Med. 2003; 139: 186-193